Who we are
Isomerase Therapeutics was founded in 2012 and is a privately-held drug discovery and development company based in Cambridge, UK.
We are an established research partner for companies looking to accelerate their discovery and development in the health and life-sciences sectors. Our outstanding commercial success was recognised in 2017 by a prestigious Queen's Award for Enterprise.
We operate a bespoke biosynthetic engineering and semisynthetic chemistry platform that can rapidly move your chosen microbial product from interesting hit to high value candidate drug or commercially attractive product. We offer our services in a flexible collaborative model to partners seeking more than just a CRO.